Page last updated: 2024-08-16

troglitazone and gft505

troglitazone has been researched along with gft505 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Chen, X; Gong, Z; Guo, F; He, H; Hou, L; Jiang, Z; Li, H; Li, J; Liu, X; Liu, Z; Long, C; Shen, L; Wang, J; Xu, D; Yuan, Z; Zhang, J; Zhang, X1

Other Studies

1 other study(ies) available for troglitazone and gft505

ArticleYear
Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis.
    ACS medicinal chemistry letters, 2019, Jul-11, Volume: 10, Issue:7

    Topics:

2019